human embryonic-stem-cell-derived cardiomyocytesregenerate non-humanprimate hearts
pluripotent stem cells provide potential solution current epidemic rates heart failure providing human cardiomyocytes support heart regeneration studies human embryonic-stem-cell-derived cardiomyocytes hesc-cms small-animal models shown favourable effects treatment- however remains unknown whether clinical-scale hesc-cm transplantation feasible safe can provide sufficient myocardial regeneration show hesc-cms can produced clinical scale one billion cells per batch cryopreserved good viability using non-human primate model myocardial ischaemia followed reperfusion show cryopreservation intramyocardial delivery one billion hesc-cms generates extensive remuscularization infarctedheart hesc-cms showed progressive incomplete maturation month period grafts perfused host vasculature electromechanical junctions graft host myocytes present within weeks engraftment importantly grafts showed regular calcium transients synchronized host electrocardiogram indicating electromechanical coupling contrast small-animal models nonfatal ventricular arrhythmias observed hesc-cm-engrafted primates thus hesc-cms can remuscularize substantial amounts infarcted monkey heart comparable remuscularization human heart possible potential arrhythmic complications need overcome
